University Hospital, Geneva
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University Hospital, Geneva sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
University Hospital, Geneva: 4 sponsored US clinical trials, 2 recruiting.
University Hospital, Geneva sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Intracranial Aneurysm, with 1 trials.
Upper-quartile sponsor footprint
University Hospital, Geneva sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
The K-Map Study, Global Prevalence of KC
NCT03115710
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
NCT05526352
BCI-controlled NMES in Subacute Stroke
NCT03379532
Quality of Life in Patients With Congenital Afibrinogenemia
NCT03484065
Therapeutic Areas
What is open in the University Hospital, Geneva pipeline
2 recruiting of 4 indexed (50% open); 2 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Intracranial Aneurysm (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University Hospital, Geneva: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
University Hospital, Geneva sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this University Hospital, Geneva page
4 registered trials is a research-attention snapshot, not an endorsement of University Hospital, Geneva or any single study.
- 2 of University Hospital, Geneva's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Intracranial Aneurysm is the condition University Hospital, Geneva studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intracranial Aneurysm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University Hospital, Geneva pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.